NCM
NGNE icon

Nantahala Capital Management’s Neurogene NGNE Stock Holding History

Nantahala Capital Management’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-42,279
Closed -$1.77M – 144
2024
Q3 		$1.77M Sell
42,279
-30,000
-42% -$1.16M 0.09% 101
2024
Q2 		$2.63M Hold
72,279
– – 0.15% 84
2024
Q1 		$3.68M Hold
72,279
– – 0.21% 76
2023
Q4 		$1.4M Sell
72,279
-2,721
-4% -$39K 0.08% 98
2023
Q3 		$1.18M Buy
+75,000
New +$1.11M 0.1% 101

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nantahala Capital Management's NGNE Position: Q4 2024 in Review

Nantahala Capital Management sold out of Neurogene (NGNE) in Q4 2024, closing a stake of 42,279 shares — an estimated $1.77M sold.

Nantahala Capital Management first reported a position in NGNE in Q3 2023 and held it in 5 quarters. The position peaked at $3.68M in Q1 2024. 88 funds tracked by Wall St. Rank hold NGNE as of Q4 2024.

  • Nantahala Capital Management reported no remaining Neurogene position as of Q4 2024 after selling out during the quarter.
  • Nantahala Capital Management sold 42,279 Neurogene shares in Q4 2024, an estimated $1.77M.
  • Nantahala Capital Management first reported a position in Neurogene in Q3 2023 and held it in 5 quarters.
  • Nantahala Capital Management's Neurogene position peaked at $3.68M in Q1 2024.
  • 88 funds tracked by Wall St. Rank held Neurogene as of Q4 2024.

Based on Nantahala Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.